Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by JackLamberton Sep 15, 2021 12:40pm
93 Views
Post# 33862316

RE:RE:RE:RE:RE:RE:RE:2020 & 2021 CC comments on acquisitions and VA contracts

RE:RE:RE:RE:RE:RE:RE:2020 & 2021 CC comments on acquisitions and VA contracts

Good points all    If it's worth anything I share your irritation.  All I can say is I keep looking at headcount patient growth and the trends in the financials and think we are going to do well

if you price the existing business the stock is about fairly priced at 27 PE.  The issue is where the future growth will be whether it's acquisition or VA or whatever.  The Royal bank called $20 plus for its upside target.  

I take comfort in the number of analysts targeting over $14.  The one recent adjustment was down a buck. Big deal. 

I remember the $5 gains in two weeks - the days of short term gratification are over. For that we have Bestobe's sister. 

<< Previous
Bullboard Posts
Next >>